2022 Agenda

Medisprof Association’s Best of ASCO Conference, 2022

GOLDEN TULIP HOTEL, CLUJ-NAPOCA, ROMANIA

‘Cupola Mică’ Conference Room and ‘Colosseum’ Conference Room

FRIDAY, JUNE 24th, 2022

SATURDAY, JUNE 25th, 2022

FOAIER: 08:00 AM - 08:20 AM
Registration and Coffee Break (20')

“CUPOLA MICĂ” CONFERENCE ROOM
08:20 - 10:10 AM

Moderator: Dr. Adrian UDREA

08:20 AM - 08:30 AM

Introduction & Welcome message (10’)
Dr. Adrian A. UDREA

MD, Medical Oncologist, Medical Director, Medisprof Cancer Center, President of Medisprof Association, Cluj-Napoca, Romania;

08:30 AM - 10:10 AM SCIENTIFIC PROGRAM

08:30 AM - 09:30 AM

Track 1: Best of ASCO - Breast cancer (60’)
Dr. Magdolna DANK

MD, Medical Oncologist, Head of Oncology, Semmelweis University of Medicine, Budapest, Hungary;

09:30 AM - 09:40 AM

Take home messages and Q&A (10’)
Dr. Andrea ONISIM

MD, Medical Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

09:40 AM - 10:00 AM

Track 2: Best of ASCO - Central Nervous System (20’)
Dr. Evangelia D. RAZIS

MD, PhD, Medical Oncologist, Director 3rd Oncology Department, Director Contemporary Oncology Team, Hygeia Hospital, Athens, Greece;

10:00 AM - 10:10 AM

Take home messages and Q&A (10’)
Dr. Claudiu HOPÎRTEAN

MD, Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania.

FOAIER: 10:10 AM - 10:25 AM
Coffee Break (15')

“COLOSSEUM” CONFERENCE ROOM -
10:25 AM -12:10 PM

Track 3: Pharma Symposia (100’) + transition time (5’)
Moderator: Dr. Andrea ONISIM

10:25 AM - 10:55 AM

1. More time for moments that matter: management of metastatic
colorectal cancer, supported by SERVIER (15’)
Dr. Crina SECEAC
MD, Medical Oncologist,Medisprof Cancer Center, Cluj-Napoca, Romania;

2. Metastatic pancreatic cancer: handling an unconventional disease, supported by SERVIER (15’)
Dr. Bogdan IONESCU
MD, Medical Oncologist,Medisprof Cancer Center, Cluj-Napoca, Romania;

10:58 AM - 11:48 AM

1. 5 years of experience with OPDIVO 2L NSCLC supported by
BRISTOL MYERS SQUIBB (15’)
Dr. Corina IONIȚĂ;

2. How has the treatment paradigm in 1L aRCC changed?,
supported by BRISTOL MYERS SQUIBB (15’)
Dr. Vlad MANOLESCU;

3. Which is the optimal sequencing for advanced melanoma
patient's BRAF mutation?, supported by BRISTOL MYERS SQUIBB
(20’)
Dr. Paul KUBELAC;

11:50 AM - 12:10 PM

Immunotherapy: an alternative that goes beyond the limits of
classical treatments in cutaneous squamous cell carcinoma,
supported by SANOFI (20’)
Dr. Tudor BOLOȘ

MD, Medical Oncologist,Medisprof Cancer Center, Cluj-Napoca, Romania;

RESTAURANT: 12:10 AM - 13:00 AM
Lunch Break (50')

“CUPOLA MICĂ” CONFERENCE ROOM
13:00 PM - 16:10 PM

SCIENTIFIC PROGRAM
Moderator: Dr. Adrian UDREA

13:00 PM - 14:30 PM

Track 4: Educational symposia (90’)

Prof. Dr. Alina M. MIHAI
MD, MS, Consultant Radiation Oncologist, Clinical Associate Professor, UCD School of Medicine, Director of Oncology Research, Beacon Hospital, Dublin, Ireland;

Dr. Pierre THIRION
MD, Consultant Radiation Oncologist, DES Radiotherapy, DESC Medical Oncology, FFRRCSI, Beacon Hospital, Dublin, Ireland;

Prof. Dr. M. Saiful HUQ
PhD, DABR, FAAPM, FinstP, Past President of AAPM, Professor, Director of Medical Physics Division, Department of Radiation Oncology, University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.

14:30 PM - 14:35 PM

Discussion time (5’)

14:35 PM - 16:05 PM

Track 5: Educational symposia (90’)

Prof. Dr. Dwight E. HERON
MD, MBA, FACRO, FACR, FCTSI Professor of Radiation Oncology, Otolaryngology and Head and Neck Surgery, Enterprise Medical Director for Oncology Services, Bon Secours Mercy Health System, Cincinnati, Ohio, USA;

Dr. Sébastien THUREAU
MD, PhD, Radiation Oncologist, Center Henri Becquerel, Rouen, France;

SBRT in RO, 1st article published in RO
Dr. Dan POP
Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

16:05 PM - 16:10 PM

Discussion time (5’)

FOAIER 16:10 PM - 16:20 PM
Coffee Break (10')

“COLOSSEUM” CONFERENCE ROOM
16:20 PM - 18:10 PM

Track 6: Pharma symposia (100’) + transition time (5’+5’)
Moderator: Dr. Andrea ONISIM

16:20 PM - 16:50 PM

Let's talk about their health and time. PHESGO, supported by
ROCHE (30’)
Dr. Andrea ONISIM

MD, Medical Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

16:55 PM - 18:10 PM

New Era for Targeting HER2 in Breast
Cancer Looking to the future, non promotional symposia supported
by ASTRAZENECA (20’)
Dr. Daniela GRECEA;

2.Tagrisso:the EGFR TKI that demonstrated unprecedented results
in advanced and incipient NSCLC supported by ASTRAZENECA (25’)
Conf. Dr. Claudia BURZ;
Lynparza in advanced ovarian cancer. Dare to Dream, supported
by ASTRAZENECA (25’)
Dr. Răzvan CURCĂ;

FOAIER 18:10 PM - 18:20 PM
Coffee Break (10')

“CUPOLA MICĂ” CONFERENCE ROOM
18:20 PM - 20:30 PM

SCIENTIFIC PROGRAM
Moderator: Dr. Adrian UDREA

18:20 PM - 19:30 PM

Track 7: Best of ASCO - Genitourinary malignancies (70’)
Prof. Dr. Petros GRIVAS

MD, PhD, Physician Seattle Cancer Care Alliance, Associate Professor, Division of Medical Oncology, University of Washington School of Medicine, Clinical Director, Genitourinary Cancers Program, UW Medicine, Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center.

19:30 PM - 19:40 PM

Take home messages and Q&A (10’)
Dr. Claudia MILITARU
MD, Medical Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

19:40 PM - 20:10 PM

Track 8: Best of ASCO - H&N slides and Sarcoma slides (30’)
Dr. Adrian A. UDREA

MD, Medical Oncologist, Medical Director, Medisprof Cancer Center, President of Medisprof Association, Cluj-Napoca, Romania;

20:10 PM - 20:20 PM

Take home messages and Q&A (10’)
Dr. Flavius I. COȘER
MD, Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

FOAIER 20:20 PM - 20:00 PM
Closing day appetizers (10')

FOAIER: 08:40 AM - 09:00 AM AM
Registration and Coffee Break (20')

“CUPOLA MICĂ” CONFERENCE ROOM
08:20 - 10:10 AM

Moderator: Dr. Adrian UDREA

09:00 AM - 11:25 AM SCIENTIFIC PROGRAM

09:00 AM - 10:00 AM

Track 9 : Best of ASCO - Gastrointestinal malignancies (60’)

Dr. Răzvan A. POPESCU

Head of Medical Oncology, Tumor Center Hirslanden, Aarau, Switzerland

10:00 AM - 10:10 AM

Take home messages and Q&A (10’)

Prof. Dr. Gabriela E. CHIOREAN

MD, Professor of Medicine, Director, GI Oncology Program, Co-Leader, Pancreas Cancer Program, Vice-Chair, National Cancer Institute- SWOG Cancer Research Network, University of Washington School of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington, USA;

10:10 AM -10:40 AM

Track 10: Educational symposia
‘Patient journey in Gastrointestinal malignancy’ (30’)

Prof. Dr. Gabriela E. CHIOREAN

10:40 AM - 10:45 AM

Discussion time (5’)

10:45 AM - 11:25 AM

Track 11: Educational symposia
”Expert panel case management - case presentations and
discussions (gastrointestinal, breast)” (40’)

Prof.Dr. Gabriela E. CHIOREAN
MD, Professor of Medicine, Director, GI Oncology Program, Co-Leader, Pancreas Cancer Program, Vice-Chair, National Cancer Institute- SWOG Cancer Research Network, University of Washington School of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington, USA;
Dr. Istvan PETAK
MD, PhD, Founder and CEO/CSO at ONCOMPASS MEDICINE, Budapest, Hungary;
Dr. Magdolna DANK
MD, Medical Oncologist, Head of Oncology, Semmelweis University of Medicine, Budapest, Hungary;
Dr. Pierre THIRION
MD, Consultant Radiation Oncologist, DES Radiotherapy, DESC Medical Oncology, FFRRCSI, Beacon Hospital, Dublin, Ireland;
Dr. Răzvan A. POPESCU
MD, Head of Medical Oncology, Tumor Center Hirslanden, Aarau, Switzerland;

FOAIER: 11:25 AM - 11:45 AM
Coffee Break (20')

“CUPOLA MICĂ” CONFERENCE ROOM -
11:25 PM – 11:45 PM

Creative Workshop powered by 10+ Art Project (20’)

Arh. Mara OPREA

Architect, founder of Format AD SRL, founding member of Project A Zece Association, Cluj-Napoca, Romania. She has about 9 years experience in architecture and interior design projects.

Arh. Iulia UDREA

Architect, founder of Arhitecți Udrea SRL, founding member of Project A Zece Association, Cluj-Napoca, Romania. She has about 10 years experience in architecture and interior design projects.

“CUPOLA MICĂ” CONFERENCE ROOM -
11:45 AM - 13:35 PM

SCIENTIFIC PROGRAM

11:45 AM - 12:45 AM

Track 12: Best of ASCO Slides - Thoracic malignancies (60’)

Prof. Dr. Delvys RODRIGUEZ-ABREU
MD, PhD, Head of Medical Oncology Department, Director of the Clinical Research Unit, Hospital Universitario Insular of Gran Canaria, Spain.
Dr. Mircea DEDIU
MD, PhD, Head of the Oncology Department, Sanador Hospital, Bucharest, Romania;

12:45 AM - 12:55 PM

Take home messages and Q&A (10’)

Dr. Mircea DEDIU
MD, PhD, Head of the Oncology Department, Sanador Hospital, Bucharest, Romania;

12:55 PM - 13:25 PM

Track 13: Best of ASCO - Gynecological Tumors (30’)

Dr. Daniela MATEI

MD, Diana Princess of Wales Professor in Cancer Research, Department of Obstetrics and Gynecology, Co-leader Translational Research in Solid Tumors Program Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA;

13:25 PM - 13:35 PM

Take home messages and Q&A (10’)
Dr. Cristian LUNGULESCU

MD, Medical Oncologist, Oncolab, Craiova, Romania;

RESTAURANT: 13:35 PM - 14:30 PM
Lunch Break (55')

“COLOSSEUM” CONFERENCE ROOM
14:30 PM - 17:25 PM

Track 14: Pharma Symposia (162’) + transition time (13’)

Moderator: Dr. Andrea ONISIM

14:30 PM - 15:00 PM

Treatment management in mCRPC, supported by ASTELLAS (30’)

Dr. Anca MIHAILOV;

15:05 PM - 16:10 PM

Treatment options for low/non expressors mNSCLC patients,
supported by MERCK SHARP & DOHME (MSD) (31’)
Dr. Cristina L. CEBOTARU
Changing the paradigm in the 1L treatment of metastatic or unresectable recurrent head and neck squamous cell carcinoma (r/m HNSCC), supported by MERCK SHARP & DOHME (MSD (31’)

Dr. Bogdan IONESCU

MD, Medical Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

Dr. Flavius I. COȘER
MD, Radiation Oncologist, Medisprof Cancer Center, Cluj-Napoca, Romania;

16:15 PM - 16:55 PM

From Clinical Trials to Real-World: Charting a new standard in
HR+/HER2- ABC, supported by PFIZER (20’)

Prof. Dr. Eva CIRUELOS, Medical Oncology Dpt. Breast CancerUnit, University Hospital 12 de Octubre, Madrid, Spain; SOLTI Breast Cancer Research Cooperative Group;

Lorviqua® (lorlatinib) efficacy in second & later lines in
advanced metastatic ALK+ NSCLC, supported by PFIZER (20’)

Dr. Mircea DEDIU, MD, PhD, Head of the Oncology Department, Sanador Hospital, Bucharest, Romania;